2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine | CAS No. 396-01-0

Q: What regulatory guidelines apply to 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine (CAS: 396-01-0)?

2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine (CAS: 396-01-0) is subject to various regulatory guidelines including the Globally Harmonized System (GHS) for classification and labeling, REACH regulations in the EU for registration, evaluation, authorization, and restriction, and FDA and EPA requirements for safety and environmental protection. Compliance with these regulations is essential for its handling and utilization.

Q: Are there alternatives to 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine in synthesis?

There are several alternatives to 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine in synthesis, including related pteridines and similar nitrogen-containing heterocycles. These alternatives can offer comparable or improved properties, making them viable options depending on the specific application requirements.

Q: What is the market or research trend for 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine?

The market for 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine is showing steady growth due to its applications in pharmaceuticals and biotechnology. Research trends are focusing on its potential as a biomarker, drug candidate, and for its use in developing novel therapeutics. Additionally, there is increasing interest in its environmental and toxicological properties.

Q: How should waste containing 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine be handled?

Waste containing 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine should be collected in appropriate containers and stored under controlled conditions to prevent degradation and potential environmental release. Incineration or professional waste disposal services are recommended for safe disposal. Environmental protection precautions, including proper handling and disposal methods, must be followed to ensure compliance with regulatory standards and minimize environmental impact.

2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine

Basic Information

View in Editor

CAS Number

396-01-0

Molecular Formula

C12H11N7

Molecular Weight

253.26 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Amines

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Basic Physical Properties

Melting Point

316 ºC

Boiling Point

386.46°C (rough estimate)

Water Solubility

<0.1 g/100 mL at 20 ºC

Flash Point

11 °C

Solubility

formic acid: soluble200 mg + 4 mL warm Formic Acid, clear, yellow-green

Refractive Index

1.8260 (estimate)

SMILES

View in Editor

C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N

InChI

InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)

InChIKey

FNYLWPVRPXGIIP-UHFFFAOYSA-N

LogP

log Kow = 0.98

pKa

6.2(at 25℃)

Complexity

307

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Hazard Class

Class 6.1(b) Class 6.1(b)

Synonyms & References

English

Esiteren
6-Phenyl-2,4,7-pteridinetriamine
Diarol
NC00544
Thiazid Wolff
Dyrenium
WLN: T66 BN DN GN JNJ CZ EZ HR& IZ
TRIAMTERENE [EP MONOGRAPH]
Ademin
TRIAMTERENE (EP MONOGRAPH)
Dytac
Urocaudal
s4080
Z275128596
Hidiurese
TRIAMTERENE (USP IMPURITY)
BSPBio_002924
FNYLWPVRPXGIIP-UHFFFAOYSA-N
SMR000059118
Tox21_110283
Dyazide (Salt/Mix)
NCGC00016016-03
BRD-K92049597-001-10-9
Diuteren
HMS3712G09
AI3-60017
NSC-77625
Dytenzide
Fluss 40
Jatropur
NCGC00016016-18

MDL Number

MFCD00006708

Customs Code

2933990090

FAQ

What regulatory guidelines apply to 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine (CAS: 396-01-0)?

2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine (CAS: 396-01-0) is subject to various regulatory guidelines including the Globally Harmonized System (GHS) for classification and labeling, REACH regulations in the EU for registration, evaluation, authorization, and restriction, and FDA and EPA requirements for safety and environmental protection. Compliance with these regulations is essential for its handling and utilization.

Are there alternatives to 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine in synthesis?

There are several alternatives to 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine in synthesis, including related pteridines and similar nitrogen-containing heterocycles. These alternatives can offer comparable or improved properties, making them viable options depending on the specific application requirements.

What is the market or research trend for 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine?

The market for 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine is showing steady growth due to its applications in pharmaceuticals and biotechnology. Research trends are focusing on its potential as a biomarker, drug candidate, and for its use in developing novel therapeutics. Additionally, there is increasing interest in its environmental and toxicological properties.

How should waste containing 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine be handled?

Waste containing 2,7-Diimino-6-phenyl-1,2,3,7-tetrahydro-4-pteridinamine should be collected in appropriate containers and stored under controlled conditions to prevent degradation and potential environmental release. Incineration or professional waste disposal services are recommended for safe disposal. Environmental protection precautions, including proper handling and disposal methods, must be followed to ensure compliance with regulatory standards and minimize environmental impact.